Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Control Bionics Ltd. ( (AU:CBL) ) is now available.
Control Bionics Ltd. announced the issuance of 42,624,175 fully paid ordinary shares without disclosure under Part 6D.2 of the Corporations Act. This move indicates the company’s compliance with relevant legal provisions, potentially strengthening its financial position and signaling confidence in its market strategy.
More about Control Bionics Ltd.
Control Bionics Ltd. operates in the technology industry, focusing on developing assistive communication devices and systems. The company primarily targets individuals with disabilities, offering innovative solutions to enhance communication capabilities.
YTD Price Performance: -30.0%
Average Trading Volume: 136,979
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$10.58M
Learn more about CBL stock on TipRanks’ Stock Analysis page.